Search clinical trials for: Cannabidiol oral solution

Total 39600 results

The Methodist Hospital Research Institute

Recruiting

CBD for Pain Following Orthopedic Shoulder Surgery (CBD)

Rotator Cuff Injuries | Shoulder Osteoarthritis

United States
Université de Sherbrooke
Canadian Institutes of Health Research (CIHR); Centre de recherche du Centre... and other collaborators

Not yet recruiting

Effect of CANnabidiol on Anxiety and GABAergic Function in Individuals With Fragile-X Syndrome (CANAX)

Fragile X Syndrome
Université de Sherbrooke
Canadian Institutes of Health Research (CIHR); Centre de recherche du Centre... and other collaborators

Not yet recruiting

Effect of CBD on the Brain

Fragile X Syndrome
Chad Brummett
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Recruiting

Cannabidiol for Postoperative Opioid Reduction in Primary Total Knee Arthroplasty (CORK)

Osteoarthritis, Knee | Knee Replacement Surgery

United States
Medical University of South Carolina

Recruiting

SCORE Emerging Adult Cannabis Use & Stress

Cannabis Use Disorder

United States
Jazz Pharmaceuticals

Recruiting

A Study to Investigate Behavioral and Other Co-Occurring Outcomes With Epidiolex as Add-On Therapy in Participants Aged 1 to 65 Years of Age With Tuberous Sclerosis Complex (EpiCom)

Tuberous Sclerosis Complex Associated Neuropsychiatric Disease

United States, United Kingdom, Poland
Meyer Children's Hospital IRCCS

Not yet recruiting

Cannabidiol in Children and Young Adults With Rare Disease-associated Severe Epilepsy (CBD_RE)

Epilepsy | Rare Diseases
University of Southern California
Medical University of South Carolina; National Institute on Aging (NIA); Alzheimer... and other collaborators

Recruiting

Life's End Benefits of Cannabidiol and Tetrahydrocannabinol (LiBBY)

Dementia | Agitation

United States
Jazz Pharmaceuticals
Evidilya S.r.l.

Not yet recruiting

Epidyolex® in Lennox Gastaut and Dravet Syndrome: an Observational Study in ITALY (EpiTALY)

Dravet Syndrome | Lennox Gastaut Syndrome

Italy
Northwell Health
Jazz Pharmaceuticals

Recruiting

Efficacy of Epidiolex in Patients With Electrical Status Epilepticus of Sleep (ESES).

Electrical Status Epilepticus of Slow-Wave Sleep

United States
Jazz Pharmaceuticals

Recruiting

Assessment of Adjunctive Cannabidiol Oral Solution (GWP42003-P) in Children With Tuberous Sclerosis Complex (TSC), Dravet Syndrome (DS), or Lennox-Gastaut Syndrome (LGS) Who Experience Inadequately-controlled Seizures

Seizure in Participants With Tuberous Sclerosis Complex | Seizure in Participants With Dravet Syndrome | Seizure in Participants With Lennox-Gastaut Syndrome

United States
University of California, San Diego
Center for Medicinal Cannabis Research

Recruiting

Effects of Cannabidiol (CBD) Versus Placebo as an Adjunct to Treatment in Early Psychosis

Early Psychosis

United States
Jazz Pharmaceuticals

Active, not recruiting

Assessment of Potential for Chronic Liver Injury in Participants Treated With Epidiolex (Cannabidiol) Oral Solution

Tuberous Sclerosis Complex | Dravet Syndrome | Lennox Gastaut Syndrome

United States
Mariana Cherner, PhD
National Institute on Drug Abuse (NIDA)

Withdrawn

CBD for Sleep in People With HIV

Sleep Disturbance

United States
The University of Texas Health Science Center at...

Completed

CBD for Dental Pain

Toothache | Odontalgia

United States
Jazz Pharmaceuticals

Completed

Trial to Investigate the Safety and Efficacy of Cannabidiol Oral Solution (GWP42003-P; CBD-OS) in Children and Adolescents With Autism Spectrum Disorder

Autism Spectrum Disorder

United States, Spain, Germany, Canada, Australia, United Kingdom
MultiCare Health System Research Institute

No longer available

Expanded Use of Cannabidiol Oral Solution

Refractory Epilepsy
Jazz Pharmaceuticals

Terminated

Efficacy and Safety of GWP42003-P Oral Solution in Children With Epilepsy With Myoclonic-atonic Seizures

Seizures Associated With EMAS

United States, Italy
Colorado State University

Completed

Cannabidiol Effects on Blood Alcohol Level and Intoxication

Alcohol Use Disorder

United States
Radius Pharmaceuticals, Inc.

Terminated

A Study to Assess RAD011 (Cannabidiol Oral Solution) for the Treatment of Participants With Prader-Willi Syndrome (SCOUT-015)

Prader-Willi Syndrome

United States
EmpowerPharm Inc.

Active, not recruiting

Cannabidiol (CBD) for the Treatment of Social Anxiety Disorder

Social Anxiety Disorder

United States
Johns Hopkins University
Dalio Foundation

Completed

Oral Cannabidiol for Opioid Withdrawal

Opioid Use Disorder | Opioid Withdrawal | Opioid Craving

United States
The University of Texas Health Science Center at...
National Center for Advancing Translational Sciences (NCATS)

Completed

Enhancing Prolonged Exposure With Cannabidiol to Treat Posttraumatic Stress Disorder

Stress Disorders, Post-Traumatic | Posttraumatic Stress Disorder

United States
Radius Pharmaceuticals, Inc.

Terminated

Cannabidiol Oral Solution for the Treatment of Patients With Prader-Willi Syndrome

Prader-Willi Syndrome

United States
Radius Pharmaceuticals, Inc.

Terminated

Cannabidiol Oral Solution in Pediatric Participants With Treatment-Resistant Childhood Absence Seizures

Childhood Absence Epilepsy

United States
Radius Pharmaceuticals, Inc.
Benuvia Therapeutics Inc.

Terminated

A Study to Assess the Long-Term Safety of Pharmaceutical Grade Synthetic Cannabidiol Oral Solution in Participants With Prader-Willi Syndrome

Prader-Willi Syndrome

United States
Radius Pharmaceuticals, Inc.
Benuvia Therapeutics Inc.

Terminated

Long-Term Safety of Pharmaceutical Grade Synthetic Cannabidiol Oral Solution in Pediatric Participants With Treatment-Resistant Childhood Absence Seizures

Childhood Absence Epilepsy

United States
Radius Pharmaceuticals, Inc.

Terminated

A Study to Assess Cannabidiol Oral Solution With Vigabatrin as Initial Therapy in Participants With Infantile Spasms

Infantile Spasm

United States
University of California, San Diego
Wholistic Research and Education Foundation

Active, not recruiting

Trial of Cannabidiol to Treat Severe Behavior Problems in Children With Autism

Autism Spectrum Disorder | Autism

United States
Radius Pharmaceuticals, Inc.

Withdrawn

A Phase 3 Extension Study of RAD011 (Cannabidiol Oral Solution) in Patients With Prader-Willi Syndrome

Prader-Willi Syndrome
Jazz Pharmaceuticals

Terminated

Efficacy and Safety of Cannabidiol Oral Solution (GWP42003-P, CBD-OS) in Patients With Rett Syndrome (ARCH)

Rett Syndrome | RTT

United States, Spain, Italy, United Kingdom
Jazz Pharmaceuticals

Withdrawn

Investigation of Cognitive Outcomes With Cannabidiol Oral Solution (EPI-COG)

Lennox-Gastaut Syndrome
Jazz Pharmaceuticals
GW Pharmaceuticals

Terminated

A Long-term Safety Study of Cannabidiol Oral Solution (GWP42003-P, CBD-OS) in Patients With Rett Syndrome

Rett Syndrome | RTT

United States, Canada, Italy, Spain, United Kingdom, Australia
Silkiss Eye Surgery
Jazz Pharmaceuticals; Smith-Kettlewell Eye Research Institute; Benign Essential...

Completed

Effect of Non-psychoactive Cannabidiol as an Adjunct to Botulinum Toxin in Blepharospasm

CBD | Blepharospasm | Blepharospasm, Benign Essential

United States
SocraTec R&D GmbH
SocraMetrics GmbH; Glatt Pharmaceutical Services GmbH & Co. KG

Completed

Cannabidiol Bioavailability Trial With Oral Multiple Dose Administration

Comparative Bioavailability

Germany
University Hospital, Basel, Switzerland

Completed

Pain Response to Cannabidiol in Induced Acute Nociceptive Pain, Allodynia and Hyperalgesia By Using a Model Mimicking Acute Pain in Healthy Adults (CANAB I)

Hyperalgesia | Allodynia | Pain Sensation

Switzerland
INSYS Therapeutics Inc

Terminated

Cannabidiol Oral Solution for Treatment of Refractory Infantile Spasms

Spasms, Infantile

United States
INSYS Therapeutics Inc

Completed

Cannabidiol Oral Solution as an Adjunctive Treatment for Treatment-resistant Seizure Disorder

Seizures

United States
INSYS Therapeutics Inc

Withdrawn

Cannabidiol Oral Solution as an Adjunctive Therapy for Treatment of Participants With Inadequately Controlled Dravet Syndrome

Dravet Syndrome
INSYS Therapeutics Inc

Withdrawn

Cannabidiol Oral Solution as an Adjunctive Therapy for Treatment of Participants With Inadequately Controlled Lennox-Gastaut Syndrome

Lennox-Gastaut Syndrome
INSYS Therapeutics Inc

Completed

Cannabidiol Oral Solution in Pediatric Participants With Treatment-resistant Seizure Disorders

Seizures

United States
Hospital Universitari Vall d'Hebron Research Institute

Not yet recruiting

Tolerability and Acceptance of Two Oral Hydrocortisone Compounding Formulation for Pediatrics

Adrenal Insufficiency

Spain
Atrogi AB

Recruiting

The Attractive 2 Trial - Pharmacokinetics of ATR-258 Oral Capsule vs. Oral Solution Formulations in Healthy Volunteers (Attractive 2)

Type2diabetes

Sweden
Calico Life Sciences LLC
AbbVie

Recruiting

Study of [14C] ABBV-CLS-7262 in Healthy Male Volunteers Following Single Oral Dose Administration

Healthy Volunteer

United States
AstraZeneca
Premier HealthCare Solutions Inc.

Recruiting

Combination Short-Acting BroNchodilator and Inhaled Corticosteroid Rescue Therapy on Health Outcomes in Routine Care (ANCHOR)

Asthma

United States
AbbVie

Recruiting

Study of Oral Ubrogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine

Migraine

United States
Fujian Provincial Hospital
Fujian Maternity and Child Health Hospital; Fujian Children's Hospital

Not yet recruiting

Intranasal Dexmedetomidine Versus Oral Midazolam Premedication for Postoperative Negative Behavior Changes in Children

Behavior Problem
Sixth Affiliated Hospital, Sun Yat-sen University

Not yet recruiting

Preoperative Oral Midazolam to Postoperative Pain Relief in Sleep Disturbance or Anxiety Patients With Colorectal Cancer (POMPPR)

Pain, Postoperative | Anxiety | Sleep Disturbance | Preoperative | Midazolam

China
Sanofi Pasteur, a Sanofi Company

Recruiting

Co-administration Study of an Investigational Live-Attenuated Respiratory Syncytial Virus Vaccine in Infants and Toddlers (CORAL)

RSV Immunization

United States
Technische Universität Dresden

Recruiting

Deep Phenotyping of Peripheral Blood Cells and Circulating Factors in Metabolic Diseases (PERIMED)

Obesity | Diabetes Mellitus | NAFLD

Germany

Search clinical trials for: Cannabidiol oral solution

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Germany

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations